ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Alector, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.95+0.11 (+5.98%)
Close on Oct 19, 2026
- Market cap
- $216.89M
- P/E (TTM)
- –
- Dividend yield
- –
Alector, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -912.4%
- Net margin
- -850.1%
- Return on equity, FY2025
- -181.6%
Financial strength
- Current ratio
- 5.26
- Debt to equity
- -0.99
- Debt to assets
- 4.9%
- Cash to current liabilities
- 175.0%
Valuation
- P/E ratio
- –
- Price to sales
- 15.65
- Price to book
- –
- Dividend yield
- –